Theratechnologies Inc. – TSX:TH.TO
Theratechnologies stock price today
Theratechnologies stock price monthly change
Theratechnologies stock price quarterly change
Theratechnologies stock price yearly change
Theratechnologies key metrics
Market Cap | 121.84M |
Enterprise value | 145.59M |
P/E | -1.59 |
EV/Sales | 1.81 |
EV/EBITDA | -5.23 |
Price/Sales | 1.28 |
Price/Book | -4.55 |
PEG ratio | 0.03 |
EPS | -0.30 |
Revenue | 78.10M |
EBITDA | -4.69M |
Income | -17.99M |
Revenue Q/Q | -18.38% |
Revenue Y/Y | -4.05% |
Profit margin | -59% |
Oper. margin | -49.85% |
Gross margin | 67.17% |
EBIT margin | -49.85% |
EBITDA margin | -6.01% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeTheratechnologies stock price history
Theratechnologies stock forecast
Theratechnologies financial statements
| May 2023 | 17.54M | -10.01M | -57.06% |
|---|---|---|---|
| Aug 2023 | 20.85M | -746K | -3.58% |
| Nov 2023 | 23.45M | -2.75M | -11.75% |
| Feb 2024 | 16.24M | -4.48M | -27.58% |
| Nov 2023 | 23.45M | -2.75M | -11.75% |
|---|---|---|---|
| Feb 2024 | 16.24M | -4.48M | -27.58% |
| Aug 2025 | 25.67M | 1.48M | 5.8% |
| Nov 2025 | 26.98M | 2.97M | 11.03% |
Analysts Price target
Financials & Ratios estimates
| May 2023 | 68733000 | 110.26M | 160.42% |
|---|---|---|---|
| Aug 2023 | 56686000 | 98.39M | 173.57% |
| Nov 2023 | 77769000 | 98.63M | 126.84% |
| Feb 2024 | 72090000 | 96.69M | 134.13% |
| May 2023 | -3.56M | 734K | -242K |
|---|---|---|---|
| Aug 2023 | 5.32M | 558K | -7.91M |
| Nov 2023 | -4.10M | 142K | 23.09M |
| Feb 2024 | -1.70M | 134K | -275K |
Theratechnologies alternative data
| Aug 2023 | 144 |
|---|---|
| Sep 2023 | 144 |
| Oct 2023 | 144 |
| Nov 2023 | 144 |
| Dec 2023 | 144 |
| Jan 2024 | 144 |
| Feb 2024 | 144 |
| Mar 2024 | 103 |
| Apr 2024 | 103 |
| May 2024 | 103 |
| Jun 2024 | 103 |
| Jul 2024 | 103 |
Theratechnologies other data
| Insider | Compensation |
|---|---|
Mr. Paul LĂ©vesque (1964) Pres, Chief Executive Officer & Director | $861,830 |
| Mr. Conor M. Walshe (1973) Gen. Mang. of Theratechnologies Europe Limited | $370,510 |
Dr. Christian Marsolais (1963) Senior Vice President & Chief Medical Officer | $357,280 |
Mr. Philippe Dubuc M.B.A., MBA (1967) Senior Vice President & Chief Financial Officer | $318,540 |
Mr. Jocelyn Lafond (1968) Vice President of Legal Affairs & Corporation Sec. | $281,340 |
-
What's the price of Theratechnologies stock today?
One share of Theratechnologies stock can currently be purchased for approximately $3.82.
-
When is Theratechnologies's next earnings date?
Unfortunately, Theratechnologies's (TH.TO) next earnings date is currently unknown.
-
Does Theratechnologies pay dividends?
No, Theratechnologies does not pay dividends.
-
How much money does Theratechnologies make?
Theratechnologies has a market capitalization of 121.84M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2.13% to 81.76M US dollars.
-
What is Theratechnologies's stock symbol?
Theratechnologies Inc. is traded on the TSX under the ticker symbol "TH.TO".
-
What is Theratechnologies's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Theratechnologies?
Shares of Theratechnologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Theratechnologies's key executives?
Theratechnologies's management team includes the following people:
- Mr. Paul LĂ©vesque Pres, Chief Executive Officer & Director(age: 61, pay: $861,830)
- Mr. Conor M. Walshe Gen. Mang. of Theratechnologies Europe Limited(age: 52, pay: $370,510)
- Dr. Christian Marsolais Senior Vice President & Chief Medical Officer(age: 62, pay: $357,280)
- Mr. Philippe Dubuc M.B.A., MBA Senior Vice President & Chief Financial Officer(age: 58, pay: $318,540)
- Mr. Jocelyn Lafond Vice President of Legal Affairs & Corporation Sec.(age: 57, pay: $281,340)
-
How many employees does Theratechnologies have?
As Jul 2024, Theratechnologies employs 103 workers.
-
When Theratechnologies went public?
Theratechnologies Inc. is publicly traded company for more then 29 years since IPO on 6 Aug 1996.
-
What is Theratechnologies's official website?
The official website for Theratechnologies is theratech.com.
-
Where are Theratechnologies's headquarters?
Theratechnologies is headquartered at 2015 Peel Street, Montreal, QC.
-
How can i contact Theratechnologies?
Theratechnologies's mailing address is 2015 Peel Street, Montreal, QC and company can be reached via phone at +1 514 336 7800.
Theratechnologies company profile:
Theratechnologies Inc.
theratech.comTSX
103
Drug Manufacturers - Specialty & Generic
Healthcare
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Montreal, QC H3A 1T8
:
ISIN: CA88338H7040
:
